Boothbay Fund Management, LLC Global Blood Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.41 Million - $2.98 Million	43,670 New	43,670 $2.97 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $480,087 - $665,355	-18,695 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $465,505 - $752,660	18,695 New	18,695 $547,000
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $461,459 - $555,243	-8,773 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $371,107 - $496,294	-9,280 Reduced 51.4%	8,773 $464,000
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $569,391 - $842,533	18,053 New	18,053 $741,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.